| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |